Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2017

Oct 31, 2017

34595_dirs_2017-10-31_baed299e-281e-4740-8819-55c59869a43f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2017-10-27

Reporting Person: Perrow Wendy (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-10-27 Director Stock Option (right to buy) $1.94 A 10000 Acquired 2025-10-27 Common Shares (10000) Direct

Footnotes

F1: The option will vest in three installments of 40%, 30% and 30%, respectively, on each of the first three anniversaries of the date of grant.